These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30102940)
1. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine. Choi IJ; Kang A; Ahn MH; Jun H; Baek SK; Park JH; Na W; Choi SO J Control Release; 2018 Sep; 286():460-466. PubMed ID: 30102940 [TBL] [Abstract][Full Text] [Related]
2. Patchless administration of canine influenza vaccine on dog's ear using insertion-responsive microneedles (IRMN) without removal of hair and its in vivo efficacy evaluation. Choi IJ; Na W; Kang A; Ahn MH; Yeom M; Kim HO; Lim JW; Choi SO; Baek SK; Song D; Park JH Eur J Pharm Biopharm; 2020 Aug; 153():150-157. PubMed ID: 32544527 [TBL] [Abstract][Full Text] [Related]
3. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825 [TBL] [Abstract][Full Text] [Related]
4. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs. Bonificio A; Ghartey-Tagoe E; Gallorini S; Baudner B; Chen G; Singh P; O'Hagan DT; Kommareddy S Vaccine; 2015 Jun; 33(25):2930-8. PubMed ID: 25930118 [TBL] [Abstract][Full Text] [Related]
5. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination. Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139 [TBL] [Abstract][Full Text] [Related]
7. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403 [TBL] [Abstract][Full Text] [Related]
8. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053 [TBL] [Abstract][Full Text] [Related]
9. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307 [TBL] [Abstract][Full Text] [Related]
10. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR Pharm Res; 2011 Jan; 28(1):135-44. PubMed ID: 20387097 [TBL] [Abstract][Full Text] [Related]
11. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch. Ameri M; Ao Y; Lewis H AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus. Wesley RD; Lager KM Am J Vet Res; 2005 Nov; 66(11):1943-7. PubMed ID: 16334954 [TBL] [Abstract][Full Text] [Related]
14. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods. Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221 [TBL] [Abstract][Full Text] [Related]
15. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection. Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023 [TBL] [Abstract][Full Text] [Related]
16. Transdermal influenza immunization with vaccine-coated microneedle arrays. Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084 [TBL] [Abstract][Full Text] [Related]
17. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses. Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557 [TBL] [Abstract][Full Text] [Related]
18. Protective efficacy and immunogenicity of an inactivated avian-origin H3N2 canine influenza vaccine in dogs challenged with the virulent virus. Lee C; Jung K; Oh J; Oh T; Han S; Hwang J; Yeom M; Son D; Kim J; Park B; Moon H; Song D; Kang B Vet Microbiol; 2010 Jul; 143(2-4):184-8. PubMed ID: 20034748 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615 [TBL] [Abstract][Full Text] [Related]
20. Dissolving polymer microneedle patches for influenza vaccination. Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]